These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10155289)

  • 1. A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.
    Garattini L; Grilli R; Scopelliti D; Mantovani L
    Pharmacoeconomics; 1995 Jan; 7(1):1-6. PubMed ID: 10155289
    [No Abstract]   [Full Text] [Related]  

  • 2. Protocol-driven costs in trial-based pharmacoeconomic analyses.
    Gandjour A
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):673-5. PubMed ID: 22098282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution?
    Alifrangis C; Krell J; Stebbing J
    Eur J Cancer; 2011 Jun; 47(9):1285-6. PubMed ID: 21550231
    [No Abstract]   [Full Text] [Related]  

  • 5. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomics: state of the art in 1997.
    Schulman KA; Linas BP
    Annu Rev Public Health; 1997; 18():529-48. PubMed ID: 9143730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much faith can we have in pharmacoeconomic analyses?
    Hatoum HT; Kong SX
    Pharmacoeconomics; 1994 Dec; 6(6):584-6. PubMed ID: 10155288
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.
    Robertson J; Lang D; Hill S
    J Clin Pharm Ther; 2003 Feb; 28(1):73-9. PubMed ID: 12605622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics in the era of individualized medicine.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2008 Aug; 84(2):179-82. PubMed ID: 18679176
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacoeconomics: evaluating the evaluators.
    Haycox A; Walley T
    Br J Clin Pharmacol; 1997 May; 43(5):451-6. PubMed ID: 9159558
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementing pharmacoeconomic outcomes management.
    McGhan WF; Briesacher BA
    Pharmacoeconomics; 1994 Nov; 6(5):412-6. PubMed ID: 10155270
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacoeconomic analyses: making them transparent, making them credible.
    Rennie D; Luft HS
    JAMA; 2000 Apr; 283(16):2158-60. PubMed ID: 10791510
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug cost management in pharmacy management based on pharmacoeconomics: Antimicrobial treatment cases.
    Liu S; He L; Sun L; Wang Y
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1069-1073. PubMed ID: 28671083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using pharmacoeconomics to value pharmacotherapy.
    Hay JW
    Clin Pharmacol Ther; 2008 Aug; 84(2):197-200. PubMed ID: 18679182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy: safety, effectiveness, and economics.
    Brandys J
    Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics of dementia.
    Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 5():S22-32; discussion S32-3. PubMed ID: 9348424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomics: determining the value of drug therapy.
    Peterson C
    Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for pharmacoeconomic studies. The ways forward.
    Drummond MF
    Pharmacoeconomics; 1994 Dec; 6(6):493-7. PubMed ID: 10155278
    [No Abstract]   [Full Text] [Related]  

  • 20. Observational studies and "real world" anesthesia pharmacoeconomics.
    Miller DR; Tierney M
    Can J Anaesth; 2002 Apr; 49(4):329-34. PubMed ID: 11927469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.